NASREEN AHMAD: Open Payments
NPI 1679117824 · BRONX, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,031 in 40 payments from 12 companies in 2025. Trend: 2023 $985 · 2024 $1,496 · 2025 $1,031
Food & beverage: $1,031
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $387 |
| Merck Sharp & Dohme LLC | 11 | $192 |
| GlaxoSmithKline, LLC. | 6 | $120 |
| Novo Nordisk Inc | 6 | $106 |
| AstraZeneca Pharmaceuticals LP | 5 | $92 |
| Recor Medical Inc | 1 | $24 |
| Lilly USA, LLC | 1 | $23 |
| Ardelyx, Inc. | 1 | $21 |
| Azurity Pharmaceuticals, Inc. | 1 | $17 |
| PFIZER INC. | 1 | $17 |
Products named: JARDIANCE, VERQUVO, FARXIGA, TRELEGY ELLIPTA, Wegovy, CAPVAXIVE, SHINGRIX, Paradise Ultrasound Renal Denervation System.
Industry payments across NY — which companies pay providers there.
